Bisphosphonates and Atypical Fractures of Femur

Bisphosphonates are the most widely prescribed medicines for the treatment of osteoporosis and have generally been regarded as well-tolerated and safe drugs. Since 2005, there have been numerous case reports about atypical fractures of the femur linked to long-term treatment of osteoporosis with bis...

Descripción completa

Detalles Bibliográficos
Autor principal: Yli-Kyyny, Tero
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096449/
https://www.ncbi.nlm.nih.gov/pubmed/21603147
http://dx.doi.org/10.4061/2011/754972
_version_ 1782203717603295232
author Yli-Kyyny, Tero
author_facet Yli-Kyyny, Tero
author_sort Yli-Kyyny, Tero
collection PubMed
description Bisphosphonates are the most widely prescribed medicines for the treatment of osteoporosis and have generally been regarded as well-tolerated and safe drugs. Since 2005, there have been numerous case reports about atypical fractures of the femur linked to long-term treatment of osteoporosis with bisphosphonates. Some attempts to characterize pathophysiology and epidemiology of these fractures have been published as well. However, as the American Society for Bone and Mineral Research (ASBMR) concluded in their task force report, the subject warrants further studies.
format Text
id pubmed-3096449
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher SAGE-Hindawi Access to Research
record_format MEDLINE/PubMed
spelling pubmed-30964492011-05-20 Bisphosphonates and Atypical Fractures of Femur Yli-Kyyny, Tero J Osteoporos Review Article Bisphosphonates are the most widely prescribed medicines for the treatment of osteoporosis and have generally been regarded as well-tolerated and safe drugs. Since 2005, there have been numerous case reports about atypical fractures of the femur linked to long-term treatment of osteoporosis with bisphosphonates. Some attempts to characterize pathophysiology and epidemiology of these fractures have been published as well. However, as the American Society for Bone and Mineral Research (ASBMR) concluded in their task force report, the subject warrants further studies. SAGE-Hindawi Access to Research 2011-03-31 /pmc/articles/PMC3096449/ /pubmed/21603147 http://dx.doi.org/10.4061/2011/754972 Text en Copyright © 2011 Tero Yli-Kyyny. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Yli-Kyyny, Tero
Bisphosphonates and Atypical Fractures of Femur
title Bisphosphonates and Atypical Fractures of Femur
title_full Bisphosphonates and Atypical Fractures of Femur
title_fullStr Bisphosphonates and Atypical Fractures of Femur
title_full_unstemmed Bisphosphonates and Atypical Fractures of Femur
title_short Bisphosphonates and Atypical Fractures of Femur
title_sort bisphosphonates and atypical fractures of femur
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096449/
https://www.ncbi.nlm.nih.gov/pubmed/21603147
http://dx.doi.org/10.4061/2011/754972
work_keys_str_mv AT ylikyynytero bisphosphonatesandatypicalfracturesoffemur

Ejemplares similares